Two new probe products helped Neoprobe Corp. narrow losses and boost revenue in 2009, but the unwinding of a complex financing deal cost the company $34 million in noncash charges. Neoprobe, which ...

Neoprobe’s President and CEO, Dr. Mark Pykett, Senior Vice President, Pharmaceutical Research and Clinical Development, Dr. Frederick Cope, and Senior Vice President and CFO, Brent Larson, will ...

Devicor Medical Products, Inc. (Devicor), a portfolio company of GTCR, a leading private equity firm, announced today the completion of its previously announced agreement to acquire the neoprobe® ...

As cancer diagnostics firm Neoprobe (NYSE Amex: NEOP) marches toward FDA approval of its “game-changing” radiopharmaceutical Lymphoseek and its share price continues to climb, many of the company’s ...

DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, today released the text of its ...

DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB: NEOP - News), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, today announced that a ...

DUBLIN, Ohio--(BUSINESS WIRE)-- Neoprobe Corporation (NYSE Amex: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, announced today that President and Chief ...

Researchers at the University of California, San Diego Cancer Center, who are working with Dublin-based Neoprobe on a breast cancer diagnosis project, have received approval from the U.S. Food and ...

It took 17 years, but Neoprobe Corp. has turned a profit. But product development expenses and the structure of Neoprobe's contract with its marketing partner will make a trip back to the black a ...